Literature DB >> 6826948

The Bezold-Jarisch reflex revisited: clinical implications of inhibitory reflexes originating in the heart.

A L Mark.   

Abstract

The concept of depressor reflexes originating in the heart was introduced by von Bezold in 1867 and was later revived by Jarisch. The Bezold-Jarisch reflex originates in cardiac sensory receptors with nonmyelinated vagal afferent pathways. The left ventricle, particularly the inferoposterior wall, is a principal location for these sensory receptors. Stimulation of these inhibitory cardiac receptors by stretch, chemical substances or drugs increases parasympathetic activity and inhibits sympathetic activity. These effects promote reflex bradycardia, vasodilation and hypotension (Bezold-Jarisch reflex) and also modulate renin release and vasopressin secretion. Conversely, decreases in the activity of these inhibitory sensory receptors reflexly increase sympathetic activity, vascular resistance, plasma renin activity and vasopressin. Long regarded as pharmacologic curiosities, it is now clear that reflexes originating in these inhibitory cardiac sensory receptors are important to the pathophysiology of many cardiovascular disorders. This paper reviews the role of inhibitory cardiac sensory receptors in several clinical states including 1) bradycardia, hypotension and gastrointestinal disorders with inferoposterior myocardial ischemia and infarction, 2) bradycardia and hypotension during coronary arteriography, 3) exertional syncope in aortic stenosis, 4) vasovagal syncope, 5) neurohumoral excitation in chronic heart failure, and 6) the therapeutic effects of digitalis.

Entities:  

Mesh:

Year:  1983        PMID: 6826948     DOI: 10.1016/s0735-1097(83)80014-x

Source DB:  PubMed          Journal:  J Am Coll Cardiol        ISSN: 0735-1097            Impact factor:   24.094


  93 in total

1.  Haemodynamic effects of increasing angle of head up tilt.

Authors:  A Zaidi; D Benitez; P A Gaydecki; A Vohra; A P Fitzpatrick
Journal:  Heart       Date:  2000-02       Impact factor: 5.994

Review 2.  Neurally mediated syncope.

Authors:  M Zaqqa; A Massumi
Journal:  Tex Heart Inst J       Date:  2000

3.  Diastolic ventricular interaction in chronic heart failure: relation to heart rate variability and neurohumoral status.

Authors:  J J Atherton; D J Blackman; T D Moore; A W Bachmann; T J Tunny; H L Thomson; R D Gordon; M P Frenneaux
Journal:  Heart Vessels       Date:  1998       Impact factor: 2.037

4.  Dysrhythmias in acute myocardial infarction: how to treat, when to treat, and when not to treat.

Authors:  J A Lopez; A Massumi
Journal:  Tex Heart Inst J       Date:  1992

5.  Predicting the outcome of head-up tilt test using heart rate variability and baroreflex sensitivity parameters in patients with vasovagal syncope.

Authors:  Matjaž Klemenc; Erik Štrumbelj
Journal:  Clin Auton Res       Date:  2015-11-07       Impact factor: 4.435

6.  Impaired blood pressure recovery to hemorrhage in obese Zucker rats with orthopedic trauma.

Authors:  Lusha Xiang; Silu Lu; William Fuller; Arun Aneja; George V Russell; Louis B Jones; Robert Hester
Journal:  Am J Physiol Heart Circ Physiol       Date:  2011-10-14       Impact factor: 4.733

7.  Syncope as a symptom of non-massive pulmonary embolism: a case report.

Authors:  Franca Dipaola; Isabella Cucchi; Nicola Filardo; Eleonora Carnovali; Nicola Montano; Raffaello Furlan; Giorgio Costantino
Journal:  Intern Emerg Med       Date:  2006       Impact factor: 3.397

Review 8.  Non-invasive risk stratification: prognostic implications of exercise testing.

Authors:  C W Israel
Journal:  Herzschrittmacherther Elektrophysiol       Date:  2007-03

9.  Nucleus tractus solitarii A(2a) adenosine receptors inhibit cardiopulmonary chemoreflex control of sympathetic outputs.

Authors:  Zeljka Minic; Donal S O'Leary; Tadeusz J Scislo
Journal:  Auton Neurosci       Date:  2013-10-25       Impact factor: 3.145

10.  Role of endogenous adenosine in vasovagal syncope.

Authors:  M Sinkovec; A Grad; P Rakovec
Journal:  Clin Auton Res       Date:  2001-06       Impact factor: 4.435

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.